EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Secukinumab Experience in a Patient With Coexistence of Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Antiphospholipid Antibody Syndrome

Enes Basaran iD, Busra Yaprak Bayrak iD, Duygu Temiz Karadag iD, Ayten Yazici iD, Ayse Cefle iD

Case Reports in Rheumatology · 2026-01 · 2026 (1)

DOI: 10.1155/crrh/4852681 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Rheumatology, online erschienen am 28.05.2026. Verfasst von Enes Basaran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey, kocaeli.edu.tr. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by autoantibody production and immune complex deposition. Antiphospholipid syndrome (APS) is frequently associated with SLE and is characterized by arterial or venous thrombosis and pregnancy morbidity in the presence of persistent antiphospholipid antibodies. The coexistence of ankylosing spondylitis (AS) with SLE and APS is extremely rare. A 38‐year‐old woman was admitted to our clinic with gangrene of the right fifth toe and swelling of both knees. She had a previous diagnosis of AS based on inflammatory low back pain and radiographic evidence of bilateral Grade 4 sacroiliitis. Laboratory investigations revealed positive antinuclear antibody, anti‐double‐stranded DNA, and antiphospholipid antibodies, including lupus anticoagulant and anti‐cardiolipin IgG. Renal biopsy performed due to proteinuria demonstrated mesangioproliferative lupus nephritis. Based on clinical, laboratory, and histopathological findings, the patient was diagnosed with coexisting AS, SLE, and APS. Considering the coexistence of these autoimmune diseases and the patient’s previous exposure to anti‐tumor necrosis factor therapy, treatment with the interleukin‐17 inhibitor secukinumab was initiated. The patient showed significant improvement in inflammatory back pain and arthritis during follow‐up. To our knowledge, this is one of the rare reported cases of coexistence of AS, SLE, and APS treated with secukinumab.

Schlagwörter

Stichwörter der Autor:innen

IL-17 inhibitorankylosing spondylitisantiphospholipid syndromesecukinumabsystemic lupus erythematosus

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey, kocaeli.edu.tr.
  • Department of Pathology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey, kocaeli.edu.tr.

ORCID-Profile: Enes Basaran, Busra Yaprak Bayrak, Duygu Temiz Karadag, Ayten Yazici, Ayse Cefle

Zitieren

APA

Basaran, E., Bayrak, B. Y., Karadag, D. T., Yazici, A., & Cefle, A. (2026). Case Report: Secukinumab Experience in a Patient With Coexistence of Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Antiphospholipid Antibody Syndrome. Case Reports in Rheumatology, 2026(1). https://doi.org/10.1155/crrh/4852681

Vancouver

Basaran E, Bayrak BY, Karadag DT, Yazici A, Cefle A. Case Report: Secukinumab Experience in a Patient With Coexistence of Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Antiphospholipid Antibody Syndrome. Case Reports in Rheumatology. 2026;2026(1). doi:10.1155/crrh/4852681

BibTeX
@article{Basaran2026,
  author = {Basaran, Enes and Bayrak, Busra Yaprak and Karadag, Duygu Temiz and Yazici, Ayten and Cefle, Ayse},
  title = {Case Report: Secukinumab Experience in a Patient With Coexistence of Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Antiphospholipid Antibody Syndrome},
  journal = {Case Reports in Rheumatology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crrh/4852681}
}
Kostenlos starten →